Trials / Not Yet Recruiting
Not Yet RecruitingNCT06638905
Efficacy and Safety of Skincare Serum and Cream for Anti-aging of Facial Skin
A Prospective, Open Label Clinical Study Evaluating the Efficacy and Safety of Skincare Serum and Cream for Anti-aging of Facial Skin
- Status
- Not Yet Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Goldman, Butterwick, Fitzpatrick and Groff · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to assess the efficacy and safety of combination therapy of BABOR® Ultimate ECM Repair Serum and the BABOR® Cure Cream for the improvement of anti-aging through the use of investigator assessments, subject questionnaires/assessments, photography, skin imaging, and reported adverse reactions.
Detailed description
Enrolled subjects will use a skin care regimen cosisting of BABOR® Ultimate ECM Repair Serum, BABOR® Cure Cream gel, mineral sunscreen, and regeneration cleanser and regeneration toner. Subjects satisfying all inclusion and exclusion criteria will be enrolled in this trial. Prior to receiving any study treatment, mandatory photography using Canfield VISIA imaging and handheld 2D photography. Patients will return for follow-up assessments at Day 30, 60, and 90.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Babor Ultimate ECM Repair Serum | The BABOR® Ultimate ECM Repair Serum contains Biogen plant extract, cotton thistle flower, and wakame extract. Babor products are encouraged to be used simultaneously mornings and/or evenings to reinforce the skin's protective barrier, promote vibrant skin, and restore skin elasticity and firmness. |
| DRUG | Babor Cure Cream | Babor products are encouraged to be used simultaneously mornings and/or evenings to reinforce the skin's protective barrier, promote vibrant skin, and restore skin elasticity and firmness. |
Timeline
- Start date
- 2024-10-28
- Primary completion
- 2025-03-05
- Completion
- 2025-05-05
- First posted
- 2024-10-15
- Last updated
- 2024-10-15
Source: ClinicalTrials.gov record NCT06638905. Inclusion in this directory is not an endorsement.